LATEST ARTICLES

Parkinson's Disease and medical cannabis

Another Survey On Cannabis Use Among Parkinson’s Patients

A survey carried out by the USA's Parkinson’s Foundation provides some insights on the use of and views on cannabis among people living with...
Using cannabis to treat migraine

Cannabis, Migraine And “Rebound” Headaches

Results from a study suggest using cannabis medicinally for migraine relief too often may also be associated with "rebound" headaches. This may not just apply...
Hemp THC levels - USDA

NASDA Continues The Push For 1% THC Hemp

The USA's National Association of State Departments of Agriculture (NASDA) has formalised its support for increasing hemp maximum THC levels. The 2018 Farm Bill defined...
New Zealand medicinal cannabis imports

NZ Medical Cannabis Imports “Out Of Control”

The New Zealand Medical Cannabis Council claims the country's government scheme is being undermined by unregulated medical cannabis imports. The NZMCC says some medical practitioners...
Illinois hemp statistics

Illinois 2020 Hemp Season Statistics

The 2020 hemp season was a challenging one for growers in the US state of Illinois, reflected in recently released harvest statistics. The Illinois Department...
Australia's CSIRO - medical cannabis

CSIRO Granted Medical Cannabis Manufacturing Licence

Australia's national science agency has been granted a manufacturing licence to develop medicinal cannabis products by the Australian Office of Drug Control. The Commonwealth Scientific...
Cannabinoid hemp in New York State

New York State Accepting Cannabinoid Hemp Program Applications

New York State Governor Andrew M. Cuomo announced on Monday that applications are being accepted for the state's Cannabinoid Hemp Program. The Program involves licencing...
CBD topical products tested

CBD Topicals Tested

Topical CBD (cannabidiol) products are becoming increasingly popular - but recent testing indicates some who use them may not be getting what they paid...
Medlab and Arrotex - Schedule 3 cannabidiol

Medlab Shoots For Schedule 3 Cannabidiol Product

Australia's Medlab (ASX: MDC) last week announced an agreement with Arrotex concerning the development and distribution of Medlab's NanoCBD cannabinoid formulation. NanoCBD contains 16.67 mg/mL...
Australian medical cannabis study

Australian Study Examining Quality Of Life For Medical Cannabis Patients

Researchers at the University of Sydney are conducting a wide-ranging study concerning quality of life issues for medicinal cannabis patients. Funded by Australian medicinal cannabis...